Zobrazeno 1 - 10
of 19
pro vyhledávání: '"I V, Karandashova"'
Autor:
V. P. Chulanov, T. A. Semenenko, I. V. Karandashova, S. V. Komarova, D. S. Kostyushev, A. P. Suslov, E. V. Volchkova
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 16, Iss 4, Pp 65-72 (2017)
The problem of the discrepancy between serotypes of the circulating strains of hepatitis B virus and serotype of the HBsAg in the vaccine is discussed. The results of published scientific studies show that hepatitis B vaccines containing HBsAg seroty
Externí odkaz:
https://doaj.org/article/c72b1fd2a08342a7bd0cc7d047894a7b
Publikováno v:
Терапевтический архив, Vol 88, Iss 3, Pp 62-67 (2016)
Aim. To clarify the role of virus resistance in the efficiency of antiviral therapy with protease inhibitors (PIs) chronic hepatitis C (CHC) patients, with moderate sensitivity to interferon-α. Subjects and methods. Eight Caucasian patients (4 men a
Externí odkaz:
https://doaj.org/article/becaae84f2504c1188c1a58b580a137d
Autor:
M. Sh. Khubutia, V. E. Sjutkin, A. A. Salienko, I. V. Karandashova, V. A. Dolgin, V. P. Chulanov, M. S. Novruzbekov
Publikováno v:
Трансплантология (Москва), Vol 0, Iss 2, Pp 5-12 (2016)
An experience of the Moscow Center for Liver Transplantation in the field of antiviral therapy of hepatitis C in recipients of liver grafts has been analyzed. From 2002 to 2012 forty nine courses of treatment were initiated in 42 patients. Eradicatio
Externí odkaz:
https://doaj.org/article/e7e1f5278de5431486dce5a03a704cde
Publikováno v:
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, Vol 21, Iss 6, Pp 49-55 (2011)
Aim. To estimate the impact of recipient IL28B genotypes on rapid (RVR) and early virologic responses (EVR) pattern in liver transplant recipients undergoing antiviral treatment (AVT).Material and methods. Blood samples were screened for single nucle
Externí odkaz:
https://doaj.org/article/236c8992d77241c18eb397e68d25636a
Publikováno v:
Терапевтический архив, Vol 84, Iss 11, Pp 61-63 (2012)
The paper gives concise data on the efficacy of entecavir in the treatment of chronic hepatitis B caused by its resistant virus strain and describes a relevant clinical case.
Externí odkaz:
https://doaj.org/article/0827987c70a44c6880672110f8c36005
Autor:
I. V. Karandashova, N. N. Pimenov, S. V. Komarova, Vladimir Chulanov, E.V. Volchkova, Welfare, Moscow, Russian Federation, N.N. Tsapkova
Publikováno v:
Infekcionnye bolezni. 16:37-45
Publikováno v:
Infekcionnye bolezni. 15:10-15
Autor:
N. N. Pimenov, D.A. Neverov, S. V. Komarova, N.A. Mamonova, V.V. Masalev, Vladimir Chulanov, О.I. Sagalova, A.I. Simakova, I. V. Karandashova, S. S Sleptsova, E. V Volchkova
Publikováno v:
Infekcionnye bolezni. 14:18-25
Autor:
V. K Semenova, I. V. Karandashova, V. P Malyi, B. D Kamolov, G. S Tomilka, S. S Sleptsova, E. V. Volchkova, Vladimir Chulanov, V. V Boiko, V. P Molochniy, N. N. Pimenov
Publikováno v:
Epidemiology and Infectious Diseases. 19:12-17
Aim: to identify features of the clinical course of hepatitis A (HA) caused by viruses of different subtypes. Patients and methods: In the study there were included 195 patients with hepatitis A (130 males and 65 females) at the age from 15 to 72 yea
Autor:
K. V Pashkina, I. V. Karandashova, S. V. Komarova, G. S. Korshunova, Vladimir Chulanov, G. V. Mikhailovskaya, E. B. Lebedeva, V. A. Dolgin, A. D. Neverov, N. N. Pimenov
Publikováno v:
Epidemiology and Infectious Diseases. 17:4-10
The article presents the results of analysis of reported incidence of acute and chronic hepatitis С in Russian Federation. Detailed description of current epidemiological characteristics of acute and chronic hepatitis С in various Federal regions a